Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Jeroen J. W. M. Janssen, Bob Löwenberg, Markus G. Manz, Bart J. Biemond, Peter E. Westerweel, Saskia K. Klein, Martin Fehr, Harm Sinnige, Anna Efthymiou, M. C. J. C. Legdeur, Thomas Pabst, Michael Gregor, Marjolein van der Poel, Dries Deeren, Lidwine W. Tick, Mojca Jongen‐Lavrencic, Florence Van Obbergh, Rinske Boersma, Okke de Weerdt, Yves Chalandon, Dominik Heim, Olivier Spertini, G. van Sluis, Carlos Graux, Georg Stüssi, Yvette van Norden, G.J. Ossenkoppele